Virtus ETF Advisers’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-43,927
| Closed | -$325K | – | 468 |
|
|
2024
Q4 | $325K | Buy |
43,927
+4,858
| +12% | +$35.9K | 0.13% | 233 |
|
|
2024
Q3 | $367K | Hold |
39,069
| – | – | 0.17% | 211 |
|
|
2024
Q2 | $313K | Buy |
39,069
+27,832
| +248% | +$223K | 0.15% | 222 |
|
|
2024
Q1 | $167K | Sell |
11,237
-771
| -6% | -$11.4K | 0.09% | 308 |
|
|
2023
Q4 | $97.6K | Buy |
12,008
+603
| +5% | +$4.9K | 0.06% | 369 |
|
|
2023
Q3 | $51.9K | Sell |
11,405
-1,137
| -9% | -$5.17K | 0.03% | 412 |
|
|
2023
Q2 | $88.3K | Sell |
12,542
-2,467
| -16% | -$17.4K | 0.05% | 421 |
|
|
2023
Q1 | $91.7K | Sell |
15,009
-5,773
| -28% | -$35.3K | 0.05% | 357 |
|
|
2022
Q4 | $133K | Buy |
20,782
+7,263
| +54% | +$46.4K | 0.07% | 385 |
|
|
2022
Q3 | $130K | Buy |
13,519
+104
| +0.8% | +$1K | 0.05% | 378 |
|
|
2022
Q2 | $148K | Buy |
13,415
+4,752
| +55% | +$52.4K | 0.05% | 320 |
|
|
2022
Q1 | $144K | Sell |
8,663
-519
| -6% | -$8.63K | 0.06% | 232 |
|
|
2021
Q4 | $175K | Buy |
9,182
+281
| +3% | +$5.36K | 0.07% | 264 |
|
|
2021
Q3 | $219K | Sell |
8,901
-470
| -5% | -$11.6K | 0.1% | 245 |
|
|
2021
Q2 | $244K | Buy |
9,371
+3,400
| +57% | +$88.5K | 0.1% | 217 |
|
|
2021
Q1 | $189K | Buy |
5,971
+101
| +2% | +$3.2K | 0.08% | 333 |
|
|
2020
Q4 | $272K | Sell |
5,870
-4,580
| -44% | -$212K | 0.11% | 267 |
|
|
2020
Q3 | $344K | Sell |
10,450
-1,419
| -12% | -$46.7K | 0.18% | 188 |
|
|
2020
Q2 | $326K | Sell |
11,869
-1,882
| -14% | -$51.7K | 0.15% | 288 |
|
|
2020
Q1 | $412K | Sell |
13,751
-2,013
| -13% | -$60.3K | 0.17% | 194 |
|
|
2019
Q4 | $436K | Buy |
15,764
+2,539
| +19% | +$70.2K | 0.07% | 229 |
|
|
2019
Q3 | $241K | Sell |
13,225
-737
| -5% | -$13.4K | 0.05% | 220 |
|
|
2019
Q2 | $342K | Buy |
+13,962
| New | +$342K | 0.07% | 197 |
|
|
2019
Q1 | – | Sell |
-30,077
| Closed | -$266K | – | 199 |
|
|
2018
Q4 | $266K | Sell |
30,077
-6,043
| -17% | -$53.4K | 0.05% | 152 |
|
|
2018
Q3 | $406K | Sell |
36,120
-25,831
| -42% | -$290K | 0.04% | 158 |
|
|
2018
Q2 | $793K | Sell |
61,951
-28,975
| -32% | -$371K | 0.7% | 34 |
|
|
2018
Q1 | $1.54M | Buy |
90,926
+50,667
| +126% | +$856K | 1.33% | 6 |
|
|
2017
Q4 | $322K | Sell |
40,259
-14,264
| -26% | -$114K | 0.4% | 113 |
|
|
2017
Q3 | $423K | Buy |
54,523
+4,987
| +10% | +$38.7K | 0.06% | 103 |
|
|
2017
Q2 | $364K | Buy |
49,536
+10,116
| +26% | +$74.3K | 0.05% | 83 |
|
|
2017
Q1 | $294K | Buy |
39,420
+3,779
| +11% | +$28.2K | 0.05% | 138 |
|
|
2016
Q4 | $248K | Buy |
35,641
+2,915
| +9% | +$20.3K | 0.07% | 146 |
|
|
2016
Q3 | $269K | Hold |
32,726
| – | – | 0.13% | 114 |
|
|
2016
Q2 | $265K | Buy |
32,726
+374
| +1% | +$3.03K | 0.2% | 74 |
|
|
2016
Q1 | $164K | Buy |
+32,352
| New | +$164K | 0.23% | 110 |
|